Dr. Nair is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
1515 Holcombe Blvd
Houston, TX 77030
Education & Training
- Medical College TrivandrumClass of 2009
Certifications & Licensure
- FL State Medical License 2021 - Present
- GA State Medical License 2022 - 2026
- TX State Medical License 2018 - 2026
- AL State Medical License 2022 - 2025
- AZ State Medical License 2022 - 2025
- LA State Medical License 2022 - 2025
- MS State Medical License 2022 - 2025
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
- Join now to see all
Clinical Trials
- A Pilot Study for Pupillary Assessment to Predict CAR-T Related Neurotoxicity Start of enrollment: 2024 Feb 08
Roles: Contact, Principal Investigator
- PACIFIC: Primary Mediastinal Large B-cell Lymphoma Treated With Antibody Therapy, Checkpoint Inhibitor in Frontline With ImmunoChemotherapy Start of enrollment: 2021 May 10
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsRadiotherapy in the treatment of primary cutaneous CD4+ small/medium T-cell lymphoproliferative disorder.Susan Y Wu, Ethan P Damron, Jie Xu, Penny Q Fang, Julia Dai
International Journal of Dermatology. 2025-02-01 - Phase 2 trial of ibrutinib in previously untreated high-risk smoldering mantle cell lymphoma.Charles Gaulin, Preetesh Jain, Ranjit Nair, Swaminathan P Iyer, Hun Ju Lee
Leukemia & Lymphoma. 2025-01-21 - Ultra-Low-Dose Radiation for Extranodal Marginal Zone Lymphoma of the Lung.Susan Y Wu, Penny Q Fang, Ahmed Fetooh, Gohar S Manzar, Kelsey L Corrigan
Advances in Radiation Oncology. 2024-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: